GlassScriptPhysician profile
Nicole Thomas
NPI 1003065509
$1,062.56
in general payments reported to CMS, 2019-2025
23 companies · $237 in 2025
The $237 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $129 · 2022: $208 · 2023: $368 · 2024: $121 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $726.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $166.02 | 2021-2025 | |
| Astellas Pharma US INC | $148.43 | 2021-2025 | Veozah, Myrbetriq |
| Corcept Therapeutics | $85.18 | 2023 | Korlym |
| Novo Nordisk INC | $79.40 | 2023-2025 | Wegovy, Saxenda |
| Acella Pharmaceuticals, LLC | $67.05 | 2022-2024 | NP Thyroid 60 |
| Exeltis, USA INC. | $56.71 | 2021-2023 | Slynd |
| Hologic Sales and Service, LLC | $50.15 | 2022-2023 | Aptima, Thinprep 2000 Processor |
| Therapeuticsmd, INC. | $44.95 | 2022 | |
| Avion Pharmaceuticals | $43.17 | 2021-2023 | Balcoltra |
| Ibsa Pharma INC. | $41.25 | 2021-2022 | |
| Coloplast Corp | $35.48 | 2025 | |
| Axsome Therapeutics, INC. | $32.44 | 2023 | Sunosi |
| Endo Pharmaceuticals INC. | $32.11 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $25.89 | 2023 | Quviviq |
| Evofem Biosciences, INC. | $23.15 | 2023 | Phexxi |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $19.02 | 2025 | |
| Emd Serono, INC. | $18.46 | 2021 | |
| Sumitomo Pharma America, INC. | $17.62 | 2025 | Gemtesa |
| Ascendis Pharma Endocrinology INC | $17.42 | 2025 | Yorvipath |
| Azurity Pharmaceuticals, INC. | $15.80 | 2023 | Adthyza |
| Acerus Pharmaceuticals Corporation | $15.57 | 2022 | |
| Clarus Therapeutics INC. | $14.02 | 2021 | |
| Exact Sciences Corporation | $13.27 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.